logo

For the Inventor, By the Inventor

Nottingham, United Kingdom

Paul Williams

This inventor holds 13 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignees: University of Nottingham, Conopco, Inc., Conopeo, Inc.. Active years: 1997-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Williams. Retrieved from https://idiyas.com/inventor/paul-williams-yf9nlc15

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 93(Granted Patents)


Company Filing History:

goldMedal7 out of 104 
 
University of Nottingham
 patents
silverMedal2 out of 1,600 
 
Conopco, Inc.
 patents
bronzeMedal1 out of 14 
 
Conopeo, Inc.
 patents
4. 1 out of 8,586 
 
Massachusetts Institute of Technology
 patents
5. 1 out of 1 
 
West Pharmaceutical Services Drug Delivery and Clinical Research Limited
 patent
6. 1 out of 1 
 
West Pharmacuetical Services Drug Delivery & Clinical
 patent
7. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2021

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 11160787 - 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one for use in the treatment of gram negative bacterial infections (2021-11-02),
2. 11083706 - Lactams for use in the treatment of skin lesions (2021-08-10),
3. 10875830 - Method of treatment (2020-12-29),
4. 10139406 - Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof (2018-11-27),
5. 9981068 - Polymers which resist bacterial attachment (2018-05-29),
6. 6602905 - N-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure (2003-08-05),
7. 6521263 - Immunomodulatory factors for immunosuppresant and antiallergic treatment (2003-02-18),
8. 6387408 - Adhesive drug delivery composition (2002-05-14),
9. 6355276 - Adhesive drug delivery composition (2002-03-12),
10. 5969158 - Method of treating allergic disease (1999-10-19),
11. 5871922 - Genes involved in the biosynthetic pathway of carbapenem (1999-02-16),
12. 5776974 - Immunosuppressant compounds (1998-07-07),
13. 5593827 - Autoinducer (1997-01-14),

Title: Paul Williams: Innovator in Pharmaceutical Patents

Introduction

Paul Williams is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bacterial infections and chronic wounds. With a total of 13 patents to his name, Williams has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents are two compounds: 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one. These compounds are designed for use in the treatment of gram-negative bacterial infections, specifically targeting infections where these bacteria are implicated. Additionally, he has developed lactams for the treatment of skin lesions, focusing on chronic wounds, including those affecting diabetic patients.

Career Highlights

Williams has worked with esteemed institutions such as the University of Nottingham and Conopco, Inc. His work has been instrumental in advancing medical treatments and improving patient outcomes. His innovative approach to pharmaceutical development has garnered attention in the scientific community.

Collaborations

Some of his notable coworkers include Barrie Walsham Bycroft and Gordon Sydney Stewart. Their collaborative efforts have contributed to the success of various projects and patents.

Conclusion

Paul Williams is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in the treatment of bacterial infections and chronic wounds. His contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…